Global Personalized Medicine for Cancer Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Description

The Personalized Medicine for Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Personalized Medicine for Cancer market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Breast Cancer accounting for  % of the Personalized Medicine for Cancer global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Immunotherapy segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Personalized Medicine for Cancer include Bayer, GlaxoSmithKline, Novartis, Sanofi, and Pfizer, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Personalized Medicine for Cancer market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Immunotherapy
    Targeted Therapy
    Chemotherapy
    Hormone Therapy
    Others

Market segment by Application, can be divided into
    Breast Cancer
    Blood Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Skin Cancer
    Lung Cancer
    Others

Market segment by players, this report covers
    Bayer
    GlaxoSmithKline
    Novartis
    Sanofi
    Pfizer
    Amgen
    Merck
    Bristol-Myers Squibb
    Ariad Pharmaceuticals (Takeda)
    Eli Lilly
    Roche
    Boehringer Ingelheim
    Johnson and Johnson
    Teva Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Personalized Medicine for Cancer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personalized Medicine for Cancer, with revenue, gross margin and global market share of Personalized Medicine for Cancer from 2019 to 2022.
Chapter 3, the Personalized Medicine for Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personalized Medicine for Cancer market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Personalized Medicine for Cancer research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Personalized Medicine for Cancer
    1.2 Classification of Personalized Medicine for Cancer by Type
        1.2.1 Overview: Global Personalized Medicine for Cancer Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Personalized Medicine for Cancer Revenue Market Share by Type in 2021
        1.2.3 Immunotherapy
        1.2.4 Targeted Therapy
        1.2.5 Chemotherapy
        1.2.6 Hormone Therapy
        1.2.7 Others
    1.3 Global Personalized Medicine for Cancer Market by Application
        1.3.1 Overview: Global Personalized Medicine for Cancer Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Breast Cancer
        1.3.3 Blood Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Skin Cancer
        1.3.7 Lung Cancer
        1.3.8 Others
    1.4 Global Personalized Medicine for Cancer Market Size & Forecast
    1.5 Global Personalized Medicine for Cancer Market Size and Forecast by Region
        1.5.1 Global Personalized Medicine for Cancer Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Personalized Medicine for Cancer Market Size by Region, (2017-2022)
        1.5.3 North America Personalized Medicine for Cancer Market Size and Prospect (2017-2028)
        1.5.4 Europe Personalized Medicine for Cancer Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Personalized Medicine for Cancer Market Size and Prospect (2017-2028)
        1.5.6 South America Personalized Medicine for Cancer Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Personalized Medicine for Cancer Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Personalized Medicine for Cancer Market Drivers
        1.6.2 Personalized Medicine for Cancer Market Restraints
        1.6.3 Personalized Medicine for Cancer Trends Analysis

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Personalized Medicine for Cancer Product and Solutions
        2.1.4 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 GlaxoSmithKline
        2.2.1 GlaxoSmithKline Details
        2.2.2 GlaxoSmithKline Major Business
        2.2.3 GlaxoSmithKline Personalized Medicine for Cancer Product and Solutions
        2.2.4 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 GlaxoSmithKline Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Personalized Medicine for Cancer Product and Solutions
        2.3.4 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Novartis Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Personalized Medicine for Cancer Product and Solutions
        2.4.4 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Personalized Medicine for Cancer Product and Solutions
        2.5.4 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Personalized Medicine for Cancer Product and Solutions
        2.6.4 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Personalized Medicine for Cancer Product and Solutions
        2.7.4 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Bristol-Myers Squibb
        2.8.1 Bristol-Myers Squibb Details
        2.8.2 Bristol-Myers Squibb Major Business
        2.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Product and Solutions
        2.8.4 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.9 Ariad Pharmaceuticals (Takeda)
        2.9.1 Ariad Pharmaceuticals (Takeda) Details
        2.9.2 Ariad Pharmaceuticals (Takeda) Major Business
        2.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Solutions
        2.9.4 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Ariad Pharmaceuticals (Takeda) Recent Developments and Future Plans
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Personalized Medicine for Cancer Product and Solutions
        2.10.4 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Eli Lilly Recent Developments and Future Plans
    2.11 Roche
        2.11.1 Roche Details
        2.11.2 Roche Major Business
        2.11.3 Roche Personalized Medicine for Cancer Product and Solutions
        2.11.4 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Roche Recent Developments and Future Plans
    2.12 Boehringer Ingelheim
        2.12.1 Boehringer Ingelheim Details
        2.12.2 Boehringer Ingelheim Major Business
        2.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Product and Solutions
        2.12.4 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.13 Johnson and Johnson
        2.13.1 Johnson and Johnson Details
        2.13.2 Johnson and Johnson Major Business
        2.13.3 Johnson and Johnson Personalized Medicine for Cancer Product and Solutions
        2.13.4 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Johnson and Johnson Recent Developments and Future Plans
    2.14 Teva Pharmaceuticals
        2.14.1 Teva Pharmaceuticals Details
        2.14.2 Teva Pharmaceuticals Major Business
        2.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Product and Solutions
        2.14.4 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Teva Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Personalized Medicine for Cancer Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Personalized Medicine for Cancer Players Market Share in 2021
        3.2.2 Top 10 Personalized Medicine for Cancer Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Personalized Medicine for Cancer Players Head Office, Products and Services Provided
    3.4 Personalized Medicine for Cancer Mergers & Acquisitions
    3.5 Personalized Medicine for Cancer New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Personalized Medicine for Cancer Revenue and Market Share by Type (2017-2022)
    4.2 Global Personalized Medicine for Cancer Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Personalized Medicine for Cancer Revenue Market Share by Application (2017-2022)
    5.2 Global Personalized Medicine for Cancer Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Personalized Medicine for Cancer Revenue by Type (2017-2028)
    6.2 North America Personalized Medicine for Cancer Revenue by Application (2017-2028)
    6.3 North America Personalized Medicine for Cancer Market Size by Country
        6.3.1 North America Personalized Medicine for Cancer Revenue by Country (2017-2028)
        6.3.2 United States Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        6.3.3 Canada Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        6.3.4 Mexico Personalized Medicine for Cancer Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Personalized Medicine for Cancer Revenue by Type (2017-2028)
    7.2 Europe Personalized Medicine for Cancer Revenue by Application (2017-2028)
    7.3 Europe Personalized Medicine for Cancer Market Size by Country
        7.3.1 Europe Personalized Medicine for Cancer Revenue by Country (2017-2028)
        7.3.2 Germany Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        7.3.3 France Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        7.3.5 Russia Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        7.3.6 Italy Personalized Medicine for Cancer Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Personalized Medicine for Cancer Revenue by Type (2017-2028)
    8.2 Asia-Pacific Personalized Medicine for Cancer Revenue by Application (2017-2028)
    8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Region
        8.3.1 Asia-Pacific Personalized Medicine for Cancer Revenue by Region (2017-2028)
        8.3.2 China Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        8.3.3 Japan Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        8.3.4 South Korea Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        8.3.5 India Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        8.3.7 Australia Personalized Medicine for Cancer Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Personalized Medicine for Cancer Revenue by Type (2017-2028)
    9.2 South America Personalized Medicine for Cancer Revenue by Application (2017-2028)
    9.3 South America Personalized Medicine for Cancer Market Size by Country
        9.3.1 South America Personalized Medicine for Cancer Revenue by Country (2017-2028)
        9.3.2 Brazil Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        9.3.3 Argentina Personalized Medicine for Cancer Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Personalized Medicine for Cancer Revenue by Type (2017-2028)
    10.2 Middle East & Africa Personalized Medicine for Cancer Revenue by Application (2017-2028)
    10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country
        10.3.1 Middle East & Africa Personalized Medicine for Cancer Revenue by Country (2017-2028)
        10.3.2 Turkey Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Personalized Medicine for Cancer Market Size and Forecast (2017-2028)
        10.3.4 UAE Personalized Medicine for Cancer Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Personalized Medicine for Cancer Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Personalized Medicine for Cancer Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Personalized Medicine for Cancer Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Personalized Medicine for Cancer Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Personalized Medicine for Cancer Revenue Market Share by Region (2023-2028)
    Table 6. Bayer Corporate Information, Head Office, and Major Competitors
    Table 7. Bayer Major Business
    Table 8. Bayer Personalized Medicine for Cancer Product and Solutions
    Table 9. Bayer Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 11. GlaxoSmithKline Major Business
    Table 12. GlaxoSmithKline Personalized Medicine for Cancer Product and Solutions
    Table 13. GlaxoSmithKline Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Novartis Corporate Information, Head Office, and Major Competitors
    Table 15. Novartis Major Business
    Table 16. Novartis Personalized Medicine for Cancer Product and Solutions
    Table 17. Novartis Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 19. Sanofi Major Business
    Table 20. Sanofi Personalized Medicine for Cancer Product and Solutions
    Table 21. Sanofi Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 23. Pfizer Major Business
    Table 24. Pfizer Personalized Medicine for Cancer Product and Solutions
    Table 25. Pfizer Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Amgen Corporate Information, Head Office, and Major Competitors
    Table 27. Amgen Major Business
    Table 28. Amgen Personalized Medicine for Cancer Product and Solutions
    Table 29. Amgen Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Merck Corporate Information, Head Office, and Major Competitors
    Table 31. Merck Major Business
    Table 32. Merck Personalized Medicine for Cancer Product and Solutions
    Table 33. Merck Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
    Table 35. Bristol-Myers Squibb Major Business
    Table 36. Bristol-Myers Squibb Personalized Medicine for Cancer Product and Solutions
    Table 37. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Ariad Pharmaceuticals (Takeda) Corporate Information, Head Office, and Major Competitors
    Table 39. Ariad Pharmaceuticals (Takeda) Major Business
    Table 40. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Solutions
    Table 41. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Eli Lilly Corporate Information, Head Office, and Major Competitors
    Table 43. Eli Lilly Major Business
    Table 44. Eli Lilly Personalized Medicine for Cancer Product and Solutions
    Table 45. Eli Lilly Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Roche Corporate Information, Head Office, and Major Competitors
    Table 47. Roche Major Business
    Table 48. Roche Personalized Medicine for Cancer Product and Solutions
    Table 49. Roche Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 51. Boehringer Ingelheim Major Business
    Table 52. Boehringer Ingelheim Personalized Medicine for Cancer Product and Solutions
    Table 53. Boehringer Ingelheim Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
    Table 55. Johnson and Johnson Major Business
    Table 56. Johnson and Johnson Personalized Medicine for Cancer Product and Solutions
    Table 57. Johnson and Johnson Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 59. Teva Pharmaceuticals Major Business
    Table 60. Teva Pharmaceuticals Personalized Medicine for Cancer Product and Solutions
    Table 61. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Global Personalized Medicine for Cancer Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 63. Global Personalized Medicine for Cancer Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 64. Breakdown of Personalized Medicine for Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Personalized Medicine for Cancer Players Head Office, Products and Services Provided
    Table 66. Personalized Medicine for Cancer Mergers & Acquisitions in the Past Five Years
    Table 67. Personalized Medicine for Cancer New Entrants and Expansion Plans
    Table 68. Global Personalized Medicine for Cancer Revenue (USD Million) by Type (2017-2022)
    Table 69. Global Personalized Medicine for Cancer Revenue Share by Type (2017-2022)
    Table 70. Global Personalized Medicine for Cancer Revenue Forecast by Type (2023-2028)
    Table 71. Global Personalized Medicine for Cancer Revenue by Application (2017-2022)
    Table 72. Global Personalized Medicine for Cancer Revenue Forecast by Application (2023-2028)
    Table 73. North America Personalized Medicine for Cancer Revenue by Type (2017-2022) & (USD Million)
    Table 74. North America Personalized Medicine for Cancer Revenue by Type (2023-2028) & (USD Million)
    Table 75. North America Personalized Medicine for Cancer Revenue by Application (2017-2022) & (USD Million)
    Table 76. North America Personalized Medicine for Cancer Revenue by Application (2023-2028) & (USD Million)
    Table 77. North America Personalized Medicine for Cancer Revenue by Country (2017-2022) & (USD Million)
    Table 78. North America Personalized Medicine for Cancer Revenue by Country (2023-2028) & (USD Million)
    Table 79. Europe Personalized Medicine for Cancer Revenue by Type (2017-2022) & (USD Million)
    Table 80. Europe Personalized Medicine for Cancer Revenue by Type (2023-2028) & (USD Million)
    Table 81. Europe Personalized Medicine for Cancer Revenue by Application (2017-2022) & (USD Million)
    Table 82. Europe Personalized Medicine for Cancer Revenue by Application (2023-2028) & (USD Million)
    Table 83. Europe Personalized Medicine for Cancer Revenue by Country (2017-2022) & (USD Million)
    Table 84. Europe Personalized Medicine for Cancer Revenue by Country (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Personalized Medicine for Cancer Revenue by Type (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Personalized Medicine for Cancer Revenue by Type (2023-2028) & (USD Million)
    Table 87. Asia-Pacific Personalized Medicine for Cancer Revenue by Application (2017-2022) & (USD Million)
    Table 88. Asia-Pacific Personalized Medicine for Cancer Revenue by Application (2023-2028) & (USD Million)
    Table 89. Asia-Pacific Personalized Medicine for Cancer Revenue by Region (2017-2022) & (USD Million)
    Table 90. Asia-Pacific Personalized Medicine for Cancer Revenue by Region (2023-2028) & (USD Million)
    Table 91. South America Personalized Medicine for Cancer Revenue by Type (2017-2022) & (USD Million)
    Table 92. South America Personalized Medicine for Cancer Revenue by Type (2023-2028) & (USD Million)
    Table 93. South America Personalized Medicine for Cancer Revenue by Application (2017-2022) & (USD Million)
    Table 94. South America Personalized Medicine for Cancer Revenue by Application (2023-2028) & (USD Million)
    Table 95. South America Personalized Medicine for Cancer Revenue by Country (2017-2022) & (USD Million)
    Table 96. South America Personalized Medicine for Cancer Revenue by Country (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Personalized Medicine for Cancer Revenue by Type (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Personalized Medicine for Cancer Revenue by Type (2023-2028) & (USD Million)
    Table 99. Middle East & Africa Personalized Medicine for Cancer Revenue by Application (2017-2022) & (USD Million)
    Table 100. Middle East & Africa Personalized Medicine for Cancer Revenue by Application (2023-2028) & (USD Million)
    Table 101. Middle East & Africa Personalized Medicine for Cancer Revenue by Country (2017-2022) & (USD Million)
    Table 102. Middle East & Africa Personalized Medicine for Cancer Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Personalized Medicine for Cancer Picture
    Figure 2. Global Personalized Medicine for Cancer Revenue Market Share by Type in 2021
    Figure 3. Immunotherapy
    Figure 4. Targeted Therapy
    Figure 5. Chemotherapy
    Figure 6. Hormone Therapy
    Figure 7. Others
    Figure 8. Personalized Medicine for Cancer Revenue Market Share by Application in 2021
    Figure 9. Breast Cancer Picture
    Figure 10. Blood Cancer Picture
    Figure 11. Gastrointestinal Cancer Picture
    Figure 12. Prostate Cancer Picture
    Figure 13. Skin Cancer Picture
    Figure 14. Lung Cancer Picture
    Figure 15. Others Picture
    Figure 16. Global Personalized Medicine for Cancer Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 17. Global Personalized Medicine for Cancer Revenue and Forecast (2017-2028) & (USD Million)
    Figure 18. Global Personalized Medicine for Cancer Revenue Market Share by Region (2017-2028)
    Figure 19. Global Personalized Medicine for Cancer Revenue Market Share by Region in 2021
    Figure 20. North America Personalized Medicine for Cancer Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Europe Personalized Medicine for Cancer Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 22. Asia-Pacific Personalized Medicine for Cancer Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 23. South America Personalized Medicine for Cancer Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 24. Middle East and Africa Personalized Medicine for Cancer Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 25. Personalized Medicine for Cancer Market Drivers
    Figure 26. Personalized Medicine for Cancer Market Restraints
    Figure 27. Personalized Medicine for Cancer Market Trends
    Figure 28. Bayer Recent Developments and Future Plans
    Figure 29. GlaxoSmithKline Recent Developments and Future Plans
    Figure 30. Novartis Recent Developments and Future Plans
    Figure 31. Sanofi Recent Developments and Future Plans
    Figure 32. Pfizer Recent Developments and Future Plans
    Figure 33. Amgen Recent Developments and Future Plans
    Figure 34. Merck Recent Developments and Future Plans
    Figure 35. Bristol-Myers Squibb Recent Developments and Future Plans
    Figure 36. Ariad Pharmaceuticals (Takeda) Recent Developments and Future Plans
    Figure 37. Eli Lilly Recent Developments and Future Plans
    Figure 38. Roche Recent Developments and Future Plans
    Figure 39. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 40. Johnson and Johnson Recent Developments and Future Plans
    Figure 41. Teva Pharmaceuticals Recent Developments and Future Plans
    Figure 42. Global Personalized Medicine for Cancer Revenue Share by Players in 2021
    Figure 43. Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 44. Global Top 3 Players Personalized Medicine for Cancer Revenue Market Share in 2021
    Figure 45. Global Top 10 Players Personalized Medicine for Cancer Revenue Market Share in 2021
    Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 47. Global Personalized Medicine for Cancer Revenue Share by Type in 2021
    Figure 48. Global Personalized Medicine for Cancer Market Share Forecast by Type (2023-2028)
    Figure 49. Global Personalized Medicine for Cancer Revenue Share by Application in 2021
    Figure 50. Global Personalized Medicine for Cancer Market Share Forecast by Application (2023-2028)
    Figure 51. North America Personalized Medicine for Cancer Sales Market Share by Type (2017-2028)
    Figure 52. North America Personalized Medicine for Cancer Sales Market Share by Application (2017-2028)
    Figure 53. North America Personalized Medicine for Cancer Revenue Market Share by Country (2017-2028)
    Figure 54. United States Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Canada Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Mexico Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Europe Personalized Medicine for Cancer Sales Market Share by Type (2017-2028)
    Figure 58. Europe Personalized Medicine for Cancer Sales Market Share by Application (2017-2028)
    Figure 59. Europe Personalized Medicine for Cancer Revenue Market Share by Country (2017-2028)
    Figure 60. Germany Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. France Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. United Kingdom Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Russia Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Italy Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Asia-Pacific Personalized Medicine for Cancer Sales Market Share by Type (2017-2028)
    Figure 66. Asia-Pacific Personalized Medicine for Cancer Sales Market Share by Application (2017-2028)
    Figure 67. Asia-Pacific Personalized Medicine for Cancer Revenue Market Share by Region (2017-2028)
    Figure 68. China Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Japan Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. South Korea Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. India Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Southeast Asia Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Australia Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. South America Personalized Medicine for Cancer Sales Market Share by Type (2017-2028)
    Figure 75. South America Personalized Medicine for Cancer Sales Market Share by Application (2017-2028)
    Figure 76. South America Personalized Medicine for Cancer Revenue Market Share by Country (2017-2028)
    Figure 77. Brazil Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Argentina Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Middle East and Africa Personalized Medicine for Cancer Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Personalized Medicine for Cancer Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Personalized Medicine for Cancer Revenue Market Share by Country (2017-2028)
    Figure 82. Turkey Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 83. Saudi Arabia Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 84. UAE Personalized Medicine for Cancer Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals